The RESCEU project aims to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics.

What is RSV? The Walton Family experience

courtesy of the University of Oxford Vaccine Group

RESCEU 2nd General Assembly (Oxford, June 2018)

RESCEU 3rd General Assembly (Utrecht, June 2019)

RSV Mortality Awareness Campaign 2019

RESCEU 4th General Assembly Meeting (Virtual meeting, 2020)

RSV Awarness Campaing 2020